Allogene Therapeutics ALLO
NASDAQ ALLO
$1.60 -0.02 (-1.54%)
As of: Sep 30, 2026 · 3:59 PM EDT

Allogene Therapeutics (ALLO) Intangibles (2018 - 2019)

Updated

Allogene Therapeutics (ALLO) posted Intangibles of $151,000 for Q4 2019, down 80.0% from $754,000 a year earlier and down 49.8% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Intangibles (2018 - 2019) Analysis & Trends

Since Q3 2018, Allogene Therapeutics has reported Intangibles for 6 quarters.

  • In prior years, Allogene Therapeutics' Intangibles was $754,000 in FY2018.
  • According to Business Quant data, Intangibles for the three prior quarters was $301,000 (Q3 2019), $452,000 (Q2 2019) and $603,000 (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 48.23 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 49.14 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 24.98 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 42.07 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 37.72 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 20.49 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 14.03 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 47.05 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 412.80 Mn
10 Allogene Therapeutics 559.46 Mn 559.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 151,000.00
Sep 30, 2019 301,000.00
Jun 30, 2019 452,000.00
Mar 31, 2019 603,000.00
Dec 31, 2018 754,000.00
Sep 30, 2018 904,000.00
API Access

Allogene Therapeutics Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=ALLO&period=max&api_key=YOUR_API_KEY